Newest
PEBO ▼ sold $76K · Augenstein Mark filed 1d agoBBT ▲ bought $105K · Hollister Thomas J filed 2d agoBBT ▼ sold $20K · Eagan John Buckley filed 2d agoGS ▼ sold $60K · LESLIE ERICKA T filed 2d agoGS ▼ sold $163K · LESLIE ERICKA T filed 2d agoMSCI ▼ sold $1.5M · Gutowski Robert J. filed 2d agoGL ▼ sold $2.2M · MAJORS MICHAEL CLAY filed 2d agoPHR ▲ bought $362 · Linetsky David filed 2d agoPHR ▲ bought $320 · Linetsky David filed 2d agoRVI ▲ bought $23K · Whitney Meredith filed 2d agoLEO ▲ bought $369K · Saba Capital Management, L.P. filed 2d agoPG ▼ sold $5.7M · Jejurikar Shailesh filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $10K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoICLR ▼ sold $15K · Lyons Emer filed 2d agoICLR ▼ sold $8K · Lyons Emer filed 2d agoPG ▼ sold $698K · Gama Paul filed 2d ago

Insider / Medtronic plc

KIIL HARRY SKIP

EVP & President Cardiovascular at Medtronic plc

Company
Medtronic plc
Ticker
MDT
First filing on record
December 9, 2025
Latest trade on record
September 16, 2026
SEC filings
EDGAR ↗

KIIL HARRY SKIP, EVP & President Cardiovascular at Medtronic plc, has disclosed 22 transactions in MDT since December 9, 2025: 0 purchases (0 open-market buys) and 11 sales, worth about $11.2M at the reported prices. The latest was filed September 17, 2026, 1 day after the trade; 11 filings were late against the 2-business-day Form 4 deadline.

Last updated September 17, 2026 · Source: SEC EDGAR Form 4 filings

Transactions
22
Open-market buys
0
Sales
11
Avg. disclosure lag
4.5d

Trading in charts

Trade timeline

When does this person trade, how big, and in which direction? Every trade in the last 12 months.

Bought (above the line)Sold (below the line)Other transaction
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep
Oct 25NovDecJan 26FebMarAprMayJunJulAugSep

In the last 12 months KIIL HARRY SKIP made no purchases and 11 sales worth $6.6M, plus 11 other transactions. Dot size is the dollar amount.

Portfolio mix

Which stocks does this person trade most? Tile size is dollars traded, all time on record.

KIIL HARRY SKIP has traded 1 stock on record; the largest by dollars is MDT.

Reporting lag

Does this person report on time? One bar per filing against the Form 4 deadline.

On timeLate
Form 4 deadlineoldest filingnewest

1 of 7 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).

What kind of transactions

Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.

Rows by Form 4 transaction code
CodeMeaningRowsSharesValue
MOption exercise or conversion8131,464$4.6M
SOpen-market sale858,196$5.6M
AGrant or award397,860—
FShares withheld for tax311,593$1.0M
Rows by year of the trade
YearRowsBoughtSold
202621010 · $6.4M
2025101 · $173K

Transactions

Download MDT trades (CSV)117 rows · 39 KB · every filer in this ticker, this insider included · all downloads

SecuritySideTrade dateDisclosedLagSharesPriceValueFlagsSourceShare
MDTSell SSeptember 16, 2026September 17, 20261d1,483$94$139KForm 4 ↗
MDTOther AAugust 3, 2026August 4, 20261d65,556——derivativeForm 4 ↗
MDTOther AAugust 3, 2026August 4, 20261d23,074——derivativeForm 4 ↗
MDTOther AAugust 3, 2026August 4, 20261d9,230——Form 4 ↗
MDTSell FJuly 31, 2026August 4, 20264d3,074$85$262KForm 4 ↗
MDTSell SJune 8, 2026June 9, 20261d228$80$18KForm 4 ↗
MDTSell SJune 8, 2026June 9, 20261d3,961$80$319KForm 4 ↗
MDTSell FJune 4, 2026June 8, 20264d6,817$83$568KForm 4 ↗
MDTOption / conversion MMay 26, 2026May 28, 20262d14,517——derivativeForm 4 ↗
MDTOption / conversion MMay 26, 2026May 28, 20262d15,195——Form 4 ↗
MDTOption / conversion MFebruary 19, 2026February 26, 20267d385——latederivativeForm 4 ↗
MDTOption / conversion MFebruary 19, 2026February 26, 20267d19,923——latederivativeForm 4 ↗
MDTOption / conversion MFebruary 19, 2026February 26, 20267d30,568——latederivativeForm 4 ↗
MDTSell SFebruary 19, 2026February 26, 20267d385$98$38KlateForm 4 ↗
MDTSell SFebruary 19, 2026February 26, 20267d668$98$65KlateForm 4 ↗
MDTSell SFebruary 19, 2026February 26, 20267d19,255$98$1.9MlateForm 4 ↗
MDTSell SFebruary 19, 2026February 26, 20267d30,568$98$3.0MlateForm 4 ↗
MDTSell SFebruary 19, 2026February 26, 20267d1,648$98$161KlateForm 4 ↗
MDTOption / conversion MFebruary 19, 2026February 26, 20267d385$80$31KlateForm 4 ↗
MDTOption / conversion MFebruary 19, 2026February 26, 20267d19,923$88$1.7MlateForm 4 ↗
MDTOption / conversion MFebruary 19, 2026February 26, 20267d30,568$93$2.8MlateForm 4 ↗
MDTSell FDecember 5, 2025December 9, 20254d1,702$101$173KForm 4 ↗

Filings

FiledFormAccessionRowsStatusSource
September 17, 2026Form 40001708062-26-0000121publishedEDGAR ↗
August 4, 2026Form 40001708062-26-0000104publishedEDGAR ↗
June 9, 2026Form 40001708062-26-0000082publishedEDGAR ↗
June 8, 2026Form 40001708062-26-0000061publishedEDGAR ↗
May 28, 2026Form 40001708062-26-0000042publishedEDGAR ↗
February 26, 2026Form 40001708062-26-00000211publishedEDGAR ↗
December 9, 2025Form 40001708062-25-0000051publishedEDGAR ↗

Other insiders at Medtronic plc

Everyone on file, with contracts and lobbying under the company's name: Medtronic plc.

Guides for this page

Sources and method

Official sources behind this page
SourceFilingsRowsFirst filedNewest filedRead the originals
SEC EDGAR, Form 4722December 9, 2025September 17, 2026Form 4 list on EDGAR

Site built October 27, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.

Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.

Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.